Data / Form D filings / MICELL TECHNOLOGIES INC
MICELL TECHNOLOGIES INC: Form D filings
MICELL TECHNOLOGIES INC, a biotechnology company in Durham, NC, filed 6 Form D notices with the SEC between 2009 and 2017. The latest, on September 19, 2017, reports $61.8 million sold of a $70 million offering to 51 investors.
Find out what MICELL TECHNOLOGIES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 801 Capitola Drive, Suite 1, Durham, NC, 27713
- Phone
- (919) 313-2102
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1060368
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 19, 2017 | Amendment | $70,000,000 | $61,775,000 | $8,225,000 | 51 | Sep 1, 2017 | sec.gov |
| Jun 21, 2017 | Amendment | $50,000,000 | $41,775,000 | $8,225,000 | 51 | Jun 16, 2017 | sec.gov |
| Apr 4, 2017 | Amendment | $35,000,000 | $31,775,000 | $3,225,000 | 51 | Mar 28, 2017 | sec.gov |
| Nov 18, 2016 | New notice | $30,000,000 | $25,775,000 | $4,225,000 | 51 | Jun 20, 2016 | sec.gov |
| Dec 3, 2009 | New notice | $300,055 | $300,055 | $0 | 12 | Nov 19, 2009 | sec.gov |
| Jul 29, 2009 | New notice | $5,300,000 | $5,000,000 | $300,000 | 9 | Jul 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy G. McMahon | Executive Officer | |
| Archibald J. Cox | Director | |
| Kenneth G. Langone | Director | |
| John G. Lowry | Director | |
| Michael G. Stansky | Director | |
| Arthur J. Benvenuto | Executive Officer, Director | |
| Robert S. Langer | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Sep 18, 2017 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MICELL TECHNOLOGIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.